Marcio Souza
Chief Executive Officer chez PRAXIS PRECISION MEDICINES, INC.
Fortune : 926 040 $ au 31/03/2024
Profil
Marcio Souza is the President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. He previously worked as the Executive Director-Marketing at NPS Pharmaceuticals, Inc. and as the Chief Operating Officer at PTC Therapeutics, Inc. He also served as an Independent Director at Clearpoint Neuro, Inc. and Spyre Therapeutics, Inc. Mr. Souza holds an MBA from Fundação Dom Cabral and an undergraduate degree from the University of Sao Paulo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2024 | 15 176 ( 0,11% ) | 926 040 $ | 31/03/2024 |
Postes actifs de Marcio Souza
| Sociétés | Poste | Début |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Chief Executive Officer | 01/04/2020 |
Anciens postes connus de Marcio Souza
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 22/06/2023 |
| CLEARPOINT NEURO, INC. | Director/Board Member | 27/04/2020 |
| PTC THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 |
| NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2014 |
Formation de Marcio Souza
| Fundação Dom Cabral | Masters Business Admin |
| University of Sao Paulo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PTC THERAPEUTICS, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| CLEARPOINT NEURO, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
| Praxis Precision Medicines, Inc. |
